A patient with a history of trigger finger of the middle finger treated with a corticosteroid injection six months ago now reports increased pain radiating to the ring finger—what could be causing this?

Worsening Pain After Trigger Finger Injection: Likely Corticosteroid-Induced Tendon Damage

This patient most likely has corticosteroid-induced tendon weakening or partial rupture of the flexor tendons, potentially affecting both the middle and ring fingers, given the 6-month timeline and radiating pain pattern.

What's Happening

The worsening pain 6 months post-injection with radiation to the adjacent ring finger suggests one of several concerning possibilities:

Most Likely: Corticosteroid-Related Tendon Injury

• Corticosteroids can weaken tendon structure and reduce tensile strength, predisposing to delayed complications 1
• Flexor tendon rupture can occur even after a single injection, with cases reported up to 2 months post-injection 2
• The guideline evidence clearly states that corticosteroids "may serve only to inhibit healing and reduce the tensile strength of the tissue, predisposing to spontaneous rupture" 1
• Structural changes from corticosteroid exposure can persist for up to 20 weeks in animal studies 3

Alternative Considerations:

• Spread of tenosynovitis to the adjacent ring finger flexor tendon
• Recurrent trigger finger (occurs in 56% of patients at 1 year) 4
• Partial tendon tear that has progressed over time
• Adjacent finger involvement from shared anatomical structures

Immediate Diagnostic Workup

Order these specific tests:

1. Ultrasound of the hand (first-line imaging)

   • Assess for tendon thickening, heterogeneous echogenicity, partial tears
   • Evaluate both middle and ring finger flexor tendons
   • Look for fluid in tendon sheaths 1

2. MRI of the hand (if ultrasound inconclusive)

   • Superior for showing partial tendon tears, chronic degenerative changes
   • Can visualize extent of tendon damage 1

3. Physical examination specifics:

   • Test active flexion strength of both middle and ring fingers
   • Palpate for tenderness along entire flexor tendon course (palm to fingertip)
   • Check for triggering, locking, or weakness with resisted flexion
   • Assess for swelling, asymmetry, or palpable tendon defects

Management Algorithm

If Tendon Rupture/Severe Damage Confirmed:

• Immediate hand surgery referral for surgical evaluation 1
• Protect the hand - avoid gripping, lifting, or strenuous activities
• Splinting to prevent further injury

If Recurrent Trigger Finger Without Rupture:

• Do NOT repeat corticosteroid injection given the concerning pain pattern and time course
• The evidence shows corticosteroids don't alter long-term outcomes and carry rupture risk 1
• Proceed directly to surgical release consultation 1

Conservative Management (Only if Mild Recurrence):

• NSAIDs for pain control 1
• Relative rest - avoid activities that worsen pain
• Ice therapy (10-minute applications through wet towel) 1
• Close monitoring - any worsening should prompt immediate surgical referral

Critical Pitfalls to Avoid

1. Do not give another corticosteroid injection - this patient has already demonstrated a poor response with worsening symptoms, and repeat injections further increase rupture risk 1, 2

2. Do not delay imaging - the radiation of pain to an adjacent finger and 6-month timeline are red flags for structural damage

3. Do not assume simple recurrence - the pattern of worsening pain (not just return of triggering) suggests something more serious than typical recurrence

4. Do not recommend "wait and see" - structural tendon damage can progress to complete rupture with continued use

Key Evidence Points

The literature consistently warns about corticosteroid complications in tendinopathy. While injections provide short-term pain relief, they carry significant risks 1. Flexor tendon rupture after even a single injection is documented 2, and the effects on tendon structure can persist for months 3. Given this patient's worsening symptoms 6 months out with adjacent finger involvement, the risk-benefit ratio strongly favors surgical evaluation over repeat injection.

Recurrence rates after injection are high (56% at 1 year) 4, but this patient's presentation - with worsening pain rather than simple return of triggering - suggests a more serious complication requiring urgent assessment and likely surgical intervention.